Solara Active Pharma Sciences Limited (BOM:541540)
499.60
+19.50 (4.06%)
At close: Feb 13, 2026
BOM:541540 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 39.5 | 84.4 | 87.3 | 463.8 | 1,977 |
Cash & Short-Term Investments | 38.7 | 39.5 | 84.4 | 87.3 | 463.8 | 1,977 |
Cash Growth | -36.24% | -53.20% | -3.32% | -81.18% | -76.54% | 252.77% |
Accounts Receivable | - | 3,266 | 3,485 | 5,370 | 4,897 | 4,839 |
Other Receivables | - | 540.6 | 481.5 | 375 | 619.7 | 572.8 |
Receivables | - | 3,807 | 3,970 | 6,071 | 6,032 | 5,428 |
Inventory | - | 3,179 | 3,597 | 5,581 | 5,756 | 2,950 |
Prepaid Expenses | - | 162.3 | 114.2 | 99.9 | 84.1 | 156.5 |
Other Current Assets | - | 100 | 241.8 | 36.2 | 57.2 | 65.2 |
Total Current Assets | - | 7,287 | 8,008 | 11,875 | 12,393 | 10,576 |
Property, Plant & Equipment | - | 10,765 | 11,142 | 11,591 | 11,374 | 9,992 |
Long-Term Investments | - | 17 | 17 | 17 | 4.2 | 4.2 |
Goodwill | - | 3,649 | 3,651 | 3,651 | 3,651 | 3,651 |
Other Intangible Assets | - | 298 | 425.6 | 543.5 | 679.4 | 799.8 |
Long-Term Deferred Tax Assets | - | - | - | 785.6 | 551.4 | 256.1 |
Other Long-Term Assets | - | 302.4 | 266.4 | 529.9 | 794 | 855 |
Total Assets | - | 22,318 | 23,510 | 28,993 | 29,450 | 26,136 |
Accounts Payable | - | 2,486 | 3,130 | 3,059 | 2,760 | 3,093 |
Accrued Expenses | - | 174.5 | 98.4 | 92.8 | 85.9 | 61.7 |
Short-Term Debt | - | 5,729 | 7,603 | 6,488 | 6,099 | 3,609 |
Current Portion of Long-Term Debt | - | 893 | 1,333 | 1,173 | 1,316 | 912 |
Current Portion of Leases | - | 22.5 | 5.1 | 5.5 | 21 | 20.5 |
Current Income Taxes Payable | - | 0.1 | 0.1 | 0.1 | 3.3 | 1.4 |
Current Unearned Revenue | - | 7.8 | 157.3 | 74.3 | 179.8 | 152.7 |
Other Current Liabilities | - | 128 | 102 | 119.5 | 169 | 37.4 |
Total Current Liabilities | - | 9,441 | 12,429 | 11,011 | 10,634 | 7,887 |
Long-Term Debt | - | 1,139 | 1,058 | 2,351 | 2,830 | 1,548 |
Long-Term Leases | - | 177.7 | 116.1 | 111.5 | 107 | 117.7 |
Long-Term Unearned Revenue | - | - | - | - | 231.3 | 284.9 |
Pension & Post-Retirement Benefits | - | 489.2 | 435.9 | 383.6 | 275.8 | 252 |
Other Long-Term Liabilities | - | 102.7 | 105 | 110.9 | 99.1 | 117.8 |
Total Liabilities | - | 11,349 | 14,144 | 13,968 | 14,178 | 10,208 |
Common Stock | - | 402.5 | 360 | 360 | 360 | 359.3 |
Additional Paid-In Capital | - | 13,687 | 12,160 | 12,160 | 12,160 | 12,117 |
Retained Earnings | - | -3,156 | -3,175 | 2,493 | 2,737 | 3,389 |
Comprehensive Income & Other | - | 9.6 | -6 | -11.3 | -8.8 | 20.3 |
Total Common Equity | 12,548 | 10,942 | 9,339 | 15,002 | 15,249 | 15,885 |
Minority Interest | - | 26.7 | 26.7 | 22.4 | 23.1 | 42.4 |
Shareholders' Equity | 12,575 | 10,969 | 9,366 | 15,025 | 15,272 | 15,928 |
Total Liabilities & Equity | - | 22,318 | 23,510 | 28,993 | 29,450 | 26,136 |
Total Debt | 6,461 | 7,961 | 10,115 | 10,129 | 10,374 | 6,207 |
Net Cash (Debt) | -6,422 | -7,921 | -10,031 | -10,041 | -9,910 | -4,230 |
Net Cash Per Share | -118.33 | -198.52 | -262.55 | -278.95 | -275.72 | -123.29 |
Filing Date Shares Outstanding | 43.79 | 48.05 | 36 | 36 | 36 | 35.93 |
Total Common Shares Outstanding | 43.79 | 48.05 | 36 | 36 | 36 | 35.93 |
Working Capital | - | -2,154 | -4,421 | 864.1 | 1,759 | 2,689 |
Book Value Per Share | 293.20 | 227.72 | 259.45 | 416.77 | 423.62 | 442.12 |
Tangible Book Value | 8,651 | 6,995 | 5,263 | 10,808 | 10,918 | 11,435 |
Tangible Book Value Per Share | 202.14 | 145.58 | 146.20 | 300.25 | 303.32 | 318.25 |
Land | - | 782.6 | 782.6 | 782.6 | 782.5 | 773 |
Buildings | - | 3,300 | 3,283 | 3,172 | 2,918 | 2,727 |
Machinery | - | 9,129 | 9,032 | 8,948 | 8,064 | 7,441 |
Construction In Progress | - | 2,801 | 2,564 | 2,385 | 2,387 | 879.8 |
Leasehold Improvements | - | 37.1 | 37.1 | 159.2 | 150 | 146.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.